2007
DOI: 10.2174/187231207783221475
|View full text |Cite
|
Sign up to set email alerts
|

Metabolite Interference in Pharmacokinetic Studies

Abstract: Our policy of conducting biotransformation studies with extended chromatography prior to pharmacokinetic bioanalyses allowed us to quickly detect an unusual, cis/trans metabolite in rat plasma that was inseparable using a short chromatographic method. We caution investigators that short methods invite unknown isobaric metabolites to cause inaccuracies in plasma concentration measurements.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2010
2010
2010
2010

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Other structural clues include carboxylic acid16 or phenol17 groups, which can be problematic due to their potential metabolic conversion into thermally unstable glucuronide conjugates. Many other potentially problematic structural motifs have been reported 6–11, 13, 18–25, 29, 31–39…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Other structural clues include carboxylic acid16 or phenol17 groups, which can be problematic due to their potential metabolic conversion into thermally unstable glucuronide conjugates. Many other potentially problematic structural motifs have been reported 6–11, 13, 18–25, 29, 31–39…”
Section: Resultsmentioning
confidence: 99%
“…Isomerization is a facile mechanism by which this type of conversion can occur 5. Reported examples of in vivo isomerization include E to Z inter‐conversion of a methyloxime‐based carbon–nitrogen double bond6 and epimerization of an alcohol group on a cyclohexane moiety 7–11. Isoxazole‐ring‐containing compounds have been shown in certain cases to undergo enzyme‐mediated ring opening to form isobaric metabolites 12, 13.…”
mentioning
confidence: 99%